The Market Reports

Synopsis
The global market for Polyisoprene Medical Surgical Gloves was estimated to be worth US$ 219 million in 2024 and is forecast to a readjusted size of US$ 346 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Polyisoprene Medical Surgical Gloves cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

In the medical industry, gloves are essential protective equipment for medical staff and play a vital role. They not only play a key role in surgical operations, but also effectively reduce the risk of bacterial infection and sharp punctures. When medical staff come into contact with patients, medical gloves are a strong guarantee for their safety, which can effectively isolate germs and prevent cross infection.

In recent years, the field of medical protection has ushered in a new type of medical gloves - polyisoprene surgical gloves, referred to as PI gloves. PI gloves use high-quality polyisoprene (PI) as raw material to create protective performance comparable to natural latex surgical gloves. It provides a solid guarantee for surgical operations, effectively protects the safety of patients and users, and helps reduce the risk of cross infection.

The current global market size of polyisoprene surgical gloves is relatively small, mainly dominated by a few raw material manufacturers such as Zeon and Cariflex and a few downstream high-end glove manufacturers. The price is much higher than natural latex and nitrile gloves, mainly meeting the needs of high-end hospitals and specific departments in developed regions such as Europe and the United States. Against the backdrop of the gradual implementation of domestic raw material localization and the continuous improvement of production processes, polyisoprene gloves are expected to break the dependence on imported raw materials and technologies, complete the localized supply closed loop, and accelerate entry into the high-end European and American markets through overseas registration and certification, realizing import substitution and value-added export dual-wheel drive. In response to trade barriers and geopolitical uncertainties, leading companies are accelerating the layout of production bases in Southeast Asia, Latin America and other places, while paying attention to the next generation of high-end latex-free protein materials similar to polyisoprene, such as functionalized synthetic latex, degradable biomaterials, etc., to maintain the dual leadership of material upgrades and cost optimization.

As the global medical industry continues to pay more attention to the risk of allergies to natural latex proteins, polyisoprene gloves have become the preferred alternative for many high-end specialties such as cardiac surgery and neurosurgery in scenarios where operation sensitivity is extremely high, thanks to their comfort and elasticity that are extremely similar to natural latex. They effectively fill the gap in comfort of traditional materials such as nitrile and chloroprene. The original positioning of polyisoprene surgical gloves was to meet the needs of high-end hospitals in developed countries for low-allergenicity and high-comfort specialty surgeries. This attribute determines its high price range, concentrated customer base and stable purchasing intention. In the post-epidemic era, the disposable protective glove industry has entered a stage of destocking and de-low-endization. Global hospitals and medical staff have relatively rigid budgets for hospital infection safety and are willing to pay for differentiated performance. The logic of polyisoprene's "high-end, low-sensitivity alternative" has become increasingly prominent.

This report aims to provide a comprehensive presentation of the global market for Polyisoprene Medical Surgical Gloves, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polyisoprene Medical Surgical Gloves by region & country, by Type, and by Application.

The Polyisoprene Medical Surgical Gloves market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polyisoprene Medical Surgical Gloves.

Market Segmentation
By Company

• HARPS Holdings
• Cardinal Health
• Hartalega Holdings Berhad
• Motex Healthcare Corp.
• WRP Asia Pacific Sdn. Bhd
• Top Glove Corporation Bhd
• HBM Protection
• O&M Halyard
• Ansell Limited
• Mölnlycke Health Care AB
• Sanko Kagaku Co., Ltd.
• Bimedica

Segment by Type
Standard Type

• Micro (ultra-thin)
• Orthopedic (thick)

Segment by Size

• 6
• 6.5
• 7
• 7.5
• 8
• Other

Segment by Application

• Hospital
• Clinic
• Other

Segment by Region

• North America: United States, Canada, and Mexico
• Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
• Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
• Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.